We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.
BDSI

Delisted

BDSI was delisted on the 22nd of March, 2022.

Back to rankings

0 hedge funds and large institutions have $0 invested in BioDelivery Sciences International, Inc. in 2022 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $26K → $0 (-$26K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
–
Holders Change
-2
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CAM
Close Asset Management
United Kingdom
-$23K
2
FCMT
Founders Capital Management (Texas)
Texas
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
CAM
1
Close Asset Management
United Kingdom
– -$23K -7,500 Closed
FCMT
2
Founders Capital Management (Texas)
Texas
– -$3K -1,000 Closed

BDSI Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2022, worth a combined $0 — down 100% from $26K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of BDSI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Close Asset Management, exiting entirely with an estimated $23K sold.

  • 0 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2022, down from 2 in Q1 2022.
  • Funds reported $0 of BioDelivery Sciences International, Inc. stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2022 and 2 closed out, a net change of -2 holders.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2022 was Close Asset Management, an estimated $23K sold.

Based on aggregated 13F filings for Q2 2022.